Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

  1. Marquinez-Alonso, I.
  2. Escudero-Vilaplana, V.
  3. Osorio, S.
  4. Rodriguez-Gonzalez, C.G.
  5. González-Haba, E.
  6. Sanjurjo-Sáez, M.
Revista:
European Journal of Hospital Pharmacy

ISSN: 2047-9964 2047-9956

Ano de publicación: 2020

Volume: 27

Número: 5

Páxinas: 299-301

Tipo: Artigo

DOI: 10.1136/EJHPHARM-2017-001378 GOOGLE SCHOLAR